Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥504.02 Million ≈ $73.75 Million USD) by net assets (CN¥9.15 Billion ≈ $1.34 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Chengdu Kanghong Pharmaceuticals Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Chengdu Kanghong Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Chengdu Kanghong Pharmaceuticals Group C debt and liabilities for a breakdown of total debt and financial obligations.

Chengdu Kanghong Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghong Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Amedisys Inc NASDAQ:AMED	0.053x
Autel Intelligent Technology Corp Ltd SHG:688208	0.008x
China Petroleum Engineering Corp SHG:600339	-0.077x
Huber+suhner AG SW:HUBN	0.100x
Liquidia Technologies Inc NASDAQ:LQDA	-0.443x
Trigano S.A. PA:TRI	0.204x
CI Financial Corp TO:CIX	0.512x
WesBanco Inc NASDAQ:WSBC	0.024x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 002773 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.65 Billion ≈ $1.27 Billion	CN¥1.41 Billion ≈ $206.60 Million	0.163x	+4.69%
2023-12-31	CN¥7.81 Billion ≈ $1.14 Billion	CN¥1.22 Billion ≈ $178.29 Million	0.156x	+16.44%
2022-12-31	CN¥6.91 Billion ≈ $1.01 Billion	CN¥925.15 Million ≈ $135.38 Million	0.134x	+65.50%
2021-12-31	CN¥6.10 Billion ≈ $893.35 Million	CN¥494.11 Million ≈ $72.30 Million	0.081x	+70.45%
2020-12-31	CN¥5.76 Billion ≈ $842.26 Million	CN¥273.32 Million ≈ $39.99 Million	0.047x	-72.98%
2019-12-31	CN¥4.62 Billion ≈ $676.13 Million	CN¥812.15 Million ≈ $118.84 Million	0.176x	+104.58%
2018-12-31	CN¥4.08 Billion ≈ $597.61 Million	CN¥350.88 Million ≈ $51.35 Million	0.086x	-60.30%
2017-12-31	CN¥3.54 Billion ≈ $518.52 Million	CN¥766.86 Million ≈ $112.22 Million	0.216x	-25.72%
2016-12-31	CN¥2.90 Billion ≈ $425.08 Million	CN¥846.35 Million ≈ $123.85 Million	0.291x	+52.64%
2015-12-31	CN¥2.52 Billion ≈ $369.49 Million	CN¥481.97 Million ≈ $70.53 Million	0.191x	+5.59%
2014-12-31	CN¥1.61 Billion ≈ $235.85 Million	CN¥291.38 Million ≈ $42.64 Million	0.181x	-24.65%
2013-12-31	CN¥1.39 Billion ≈ $203.30 Million	CN¥333.31 Million ≈ $48.77 Million	0.240x	-5.84%
2012-12-31	CN¥1.11 Billion ≈ $161.87 Million	CN¥281.84 Million ≈ $41.24 Million	0.255x	+41.29%
2011-12-31	CN¥936.39 Million ≈ $137.02 Million	CN¥168.86 Million ≈ $24.71 Million	0.180x	-17.63%
2010-12-31	CN¥624.85 Million ≈ $91.44 Million	CN¥136.79 Million ≈ $20.02 Million	0.219x	+8.98%
2009-12-31	CN¥539.75 Million ≈ $78.98 Million	CN¥108.42 Million ≈ $15.87 Million	0.201x	--

About Chengdu Kanghong Pharmaceuticals Group Co Ltd

SHE:002773 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.32 Billion

CN¥22.69 Billion CNY

Market Cap Rank

#4635 Global

#853 in China

Share Price

CN¥24.63

Change (1 day)

-1.00%

52-Week Range

CN¥24.49 - CN¥46.13

All Time High

CN¥52.89